Selected research
Industry Research
Topical Drugs Glass Packaging Industry Research Report 2026
Market perspective
The global Topical Drugs Glass Packaging market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Topical Drugs Glass Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Topical Drugs Glass Packaging is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Topical Drugs Glass Packaging is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Topical Drugs Glass Packaging include Origin Pharma Packaging, Halo Pharma, Johnson & Johnson, Novartis AG, GlaxoSmithKline, Bausch Health companies, Merk & Co, Bayer AG and Aphena Pharma Solutions, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Topical Drugs Glass Packaging market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Topical Drugs Glass Packaging Market by Company
Origin Pharma Packaging
Halo Pharma
Johnson & Johnson
Novartis AG
GlaxoSmithKline
Bausch Health companies
Merk & Co
Bayer AG
Aphena Pharma Solutions
Glenmark Pharmaceuticals
Allergan
West Pharmaceutical Services
Encore Dermatology
Aclaris Therapeutics
Topical Drugs Glass Packaging Segment by Type
Liquid Medicine
Solid Medicine
Semi-Solid Medicine
Topical Drugs Glass Packaging Segment by Application
Hospital
Clinic
Other
Topical Drugs Glass Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Drugs Glass Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Topical Drugs Glass Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Drugs Glass Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Topical Drugs Glass Packaging manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Topical Drugs Glass Packaging by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Topical Drugs Glass Packaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid Medicine
- Solid Medicine
- Semi-Solid Medicine
Applications
- Hospital
- Clinic
- Other
Companies covered
- Origin Pharma Packaging
- Halo Pharma
- Johnson & Johnson
- Novartis AG
- GlaxoSmithKline
- Bausch Health companies
- Merk & Co
- Bayer AG
- Aphena Pharma Solutions
- Glenmark Pharmaceuticals
- Allergan
- West Pharmaceutical Services
- Encore Dermatology
- Aclaris Therapeutics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Topical Drugs Glass Packaging Market Size (2021-2032)
- 2.2.2 Global Topical Drugs Glass Packaging Sales (2021-2032)
- 2.2.3 Global Topical Drugs Glass Packaging Market Average Price (2021-2032)
- 2.3 Topical Drugs Glass Packaging by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Liquid Medicine
- 2.3.3 Solid Medicine
- 2.3.4 Semi-Solid Medicine
- 2.4 Topical Drugs Glass Packaging by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Topical Drugs Glass Packaging Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Topical Drugs Glass Packaging Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Topical Drugs Glass Packaging Revenue of Manufacturers (2021-2026)
- 3.4 Global Topical Drugs Glass Packaging Average Price by Manufacturers (2021-2026)
- 3.5 Global Topical Drugs Glass Packaging Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Topical Drugs Glass Packaging, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Topical Drugs Glass Packaging, Product Type & Application
- 3.8 Global Manufacturers of Topical Drugs Glass Packaging, Established Date
- 3.9 Global Topical Drugs Glass Packaging Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Origin Pharma Packaging
- 4.1.1 Origin Pharma Packaging Company Information
- 4.1.2 Origin Pharma Packaging Business Overview
- 4.1.3 Origin Pharma Packaging Topical Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Origin Pharma Packaging Topical Drugs Glass Packaging Product Portfolio
- 4.1.5 Origin Pharma Packaging Recent Developments
- 4.2 Halo Pharma
- 4.2.1 Halo Pharma Company Information
- 4.2.2 Halo Pharma Business Overview
- 4.2.3 Halo Pharma Topical Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Halo Pharma Topical Drugs Glass Packaging Product Portfolio
- 4.2.5 Halo Pharma Recent Developments
- 4.3 Johnson & Johnson
- 4.3.1 Johnson & Johnson Company Information
- 4.3.2 Johnson & Johnson Business Overview
- 4.3.3 Johnson & Johnson Topical Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Johnson & Johnson Topical Drugs Glass Packaging Product Portfolio
- 4.3.5 Johnson & Johnson Recent Developments
- 4.4 Novartis AG
- 4.4.1 Novartis AG Company Information
- 4.4.2 Novartis AG Business Overview
- 4.4.3 Novartis AG Topical Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis AG Topical Drugs Glass Packaging Product Portfolio
- 4.4.5 Novartis AG Recent Developments
- 4.5 GlaxoSmithKline
- 4.5.1 GlaxoSmithKline Company Information
- 4.5.2 GlaxoSmithKline Business Overview
- 4.5.3 GlaxoSmithKline Topical Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 GlaxoSmithKline Topical Drugs Glass Packaging Product Portfolio
- 4.5.5 GlaxoSmithKline Recent Developments
- 4.6 Bausch Health companies
- 4.6.1 Bausch Health companies Company Information
- 4.6.2 Bausch Health companies Business Overview
- 4.6.3 Bausch Health companies Topical Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bausch Health companies Topical Drugs Glass Packaging Product Portfolio
- 4.6.5 Bausch Health companies Recent Developments
- 4.7 Merk & Co
- 4.7.1 Merk & Co Company Information
- 4.7.2 Merk & Co Business Overview
- 4.7.3 Merk & Co Topical Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merk & Co Topical Drugs Glass Packaging Product Portfolio
- 4.7.5 Merk & Co Recent Developments
- 4.8 Bayer AG
- 4.8.1 Bayer AG Company Information
- 4.8.2 Bayer AG Business Overview
- 4.8.3 Bayer AG Topical Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bayer AG Topical Drugs Glass Packaging Product Portfolio
- 4.8.5 Bayer AG Recent Developments
- 4.9 Aphena Pharma Solutions
- 4.9.1 Aphena Pharma Solutions Company Information
- 4.9.2 Aphena Pharma Solutions Business Overview
- 4.9.3 Aphena Pharma Solutions Topical Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Aphena Pharma Solutions Topical Drugs Glass Packaging Product Portfolio
- 4.9.5 Aphena Pharma Solutions Recent Developments
- 4.10 Glenmark Pharmaceuticals
- 4.10.1 Glenmark Pharmaceuticals Company Information
- 4.10.2 Glenmark Pharmaceuticals Business Overview
- 4.10.3 Glenmark Pharmaceuticals Topical Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Glenmark Pharmaceuticals Topical Drugs Glass Packaging Product Portfolio
- 4.10.5 Glenmark Pharmaceuticals Recent Developments
- 4.11 Allergan
- 4.11.1 Allergan Company Information
- 4.11.2 Allergan Business Overview
- 4.11.3 Allergan Topical Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Allergan Topical Drugs Glass Packaging Product Portfolio
- 4.11.5 Allergan Recent Developments
- 4.12 West Pharmaceutical Services
- 4.12.1 West Pharmaceutical Services Company Information
- 4.12.2 West Pharmaceutical Services Business Overview
- 4.12.3 West Pharmaceutical Services Topical Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 West Pharmaceutical Services Topical Drugs Glass Packaging Product Portfolio
- 4.12.5 West Pharmaceutical Services Recent Developments
- 4.13 Encore Dermatology
- 4.13.1 Encore Dermatology Company Information
- 4.13.2 Encore Dermatology Business Overview
- 4.13.3 Encore Dermatology Topical Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Encore Dermatology Topical Drugs Glass Packaging Product Portfolio
- 4.13.5 Encore Dermatology Recent Developments
- 4.14 Aclaris Therapeutics
- 4.14.1 Aclaris Therapeutics Company Information
- 4.14.2 Aclaris Therapeutics Business Overview
- 4.14.3 Aclaris Therapeutics Topical Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Aclaris Therapeutics Topical Drugs Glass Packaging Product Portfolio
- 4.14.5 Aclaris Therapeutics Recent Developments
5 Global Topical Drugs Glass Packaging Market Scenario by Region
- 5.1 Global Topical Drugs Glass Packaging Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Topical Drugs Glass Packaging Sales by Region: 2021-2032
- 5.2.1 Global Topical Drugs Glass Packaging Sales by Region: 2021-2026
- 5.2.2 Global Topical Drugs Glass Packaging Sales by Region: 2027-2032
- 5.3 Global Topical Drugs Glass Packaging Revenue by Region: 2021-2032
- 5.3.1 Global Topical Drugs Glass Packaging Revenue by Region: 2021-2026
- 5.3.2 Global Topical Drugs Glass Packaging Revenue by Region: 2027-2032
- 5.4 North America Topical Drugs Glass Packaging Market Facts & Figures by Country
- 5.4.1 North America Topical Drugs Glass Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Topical Drugs Glass Packaging Sales by Country (2021-2032)
- 5.4.3 North America Topical Drugs Glass Packaging Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Topical Drugs Glass Packaging Market Facts & Figures by Country
- 5.5.1 Europe Topical Drugs Glass Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Topical Drugs Glass Packaging Sales by Country (2021-2032)
- 5.5.3 Europe Topical Drugs Glass Packaging Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Topical Drugs Glass Packaging Market Facts & Figures by Country
- 5.6.1 Asia Pacific Topical Drugs Glass Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Topical Drugs Glass Packaging Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Topical Drugs Glass Packaging Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Topical Drugs Glass Packaging Market Facts & Figures by Country
- 5.7.1 South America Topical Drugs Glass Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Topical Drugs Glass Packaging Sales by Country (2021-2032)
- 5.7.3 South America Topical Drugs Glass Packaging Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Topical Drugs Glass Packaging Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Topical Drugs Glass Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Topical Drugs Glass Packaging Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Topical Drugs Glass Packaging Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Topical Drugs Glass Packaging Sales by Type (2021-2032)
- 6.1.1 Global Topical Drugs Glass Packaging Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Topical Drugs Glass Packaging Sales Market Share by Type (2021-2032)
- 6.2 Global Topical Drugs Glass Packaging Revenue by Type (2021-2032)
- 6.2.1 Global Topical Drugs Glass Packaging Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Topical Drugs Glass Packaging Revenue Market Share by Type (2021-2032)
- 6.3 Global Topical Drugs Glass Packaging Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Topical Drugs Glass Packaging Sales by Application (2021-2032)
- 7.1.1 Global Topical Drugs Glass Packaging Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Topical Drugs Glass Packaging Sales Market Share by Application (2021-2032)
- 7.2 Global Topical Drugs Glass Packaging Revenue by Application (2021-2032)
- 7.2.1 Global Topical Drugs Glass Packaging Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Topical Drugs Glass Packaging Revenue Market Share by Application (2021-2032)
- 7.3 Global Topical Drugs Glass Packaging Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Topical Drugs Glass Packaging Value Chain Analysis
- 8.1.1 Topical Drugs Glass Packaging Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Topical Drugs Glass Packaging Production Mode & Process
- 8.2 Topical Drugs Glass Packaging Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Topical Drugs Glass Packaging Distributors
- 8.2.3 Topical Drugs Glass Packaging Customers
9 Global Topical Drugs Glass Packaging Analyzing Market Dynamics
- 9.1 Topical Drugs Glass Packaging Industry Trends
- 9.2 Topical Drugs Glass Packaging Industry Drivers
- 9.3 Topical Drugs Glass Packaging Industry Opportunities and Challenges
- 9.4 Topical Drugs Glass Packaging Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst